Back to search
FDAFDA · Food and drugs·Recall number Z-2651-2026

IQon Spectral CT IQon Spectral CT Upgrades

Published August 5, 2026 · Recall initiated: June 11, 2026

Summary

FDA records medical device Class II recall Z-2651-2026, published August 5, 2026 and initiated June 11, 2026. Recalling firm: PHILIPS MEDICAL SYSTEMS; Status: Ongoing; Reported quantity: 42; Lot: FCO72800812; FCO72800814 728331 728332, DI (01)00884838059542. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The clinical CT scan may not automatically trigger after the Bolus Tracking scan and may need to be triggered manually. Additional Bolus Tracking shots may occur. This may result in the clinical acquisition being inadequate for diagnosis, causing a potential for patient rescan and receiving additional radiation.

What to do

FDA Mandated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
PHILIPS MEDICAL SYSTEMS
Distributor
US Nationwide Distribution including Puerto Rico
Lot
FCO72800812; FCO72800814 728331 728332, DI (01)00884838059542
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was IQon Spectral CT IQon Spectral CT Upgrades recalled?

Yes. FDA published recall Z-2651-2026 on August 5, 2026. Reported hazard: The clinical CT scan may not automatically trigger after the Bolus Tracking scan and may need to be triggered manually. Additional Bolus Tracking shots may occur. This may result in the clinical acquisition being inadequate for diagnosis, causing a potential for patient rescan and receiving additional radiation.

What should I do if I have this product?

FDA Mandated · Letter